Pharmacokinetics and Pharmacodynamics of Biological Drugs, 7.5 credits

Academic year 2022/2023

  • Autumn 2022, 100%, Campus

    Start date: 30 November 2022

    End date: 15 January 2023

    Application deadline: 19 April 2022

    Application code: UU-39203 Application

    Language of instruction: English

    Location: Uppsala

    Selection: Higher education credits (maximum 285 credits)

    Registration: 23 November 2022 – 30 January 2023

Entry requirements: Entry requirements:
The programme in Master of Science in Pharmacy: at least 150 credits within the programme including passed courses in pharmacokinetics 7.5 credits, pharmacology and physiology. Furthermore, registration at all earlier courses within the pharmacy program is required
The programme in Master of Science in Chemical Engineering: at least 150 credits within the programme is required, and courses corresponding to Pharmacokinetics 7.5 credits, Physiology 6 credits and Pharmacology 7.5 credits 
Master Programme in Biological drugs: admitted and complied prior courses within the program
Master Programme in Drug Discovery and Development: admitted and complied prior courses within the program 
Master Programme in Pharmaceutical Modelling: admitted and complied prior courses within the program
Acceptance to a single subject course requires a) basic qualification according to the higher education ordinance (150 credits), and b) knowledge corresponding to 60 credits within the subject Pharmacy, Pharmaceutical science, or Pharmaceutical bioscience, including Pharmacokinetics 7.5 credits, and c) knowledge corresponding to Physiology 6 credits and Pharmacology 7.5 credits


If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application or tuition fees. Formal exchange students will be exempted from tuition fees, as well as the application fee. Read more about fees.

Application fee: SEK 900

Tuition fee, first semester: SEK 18,125

Tuition fee, total: SEK 18,125

About the course

The course provides a detailed picture of how different biological medicines are distributed and eliminated and how different target structures and disease states can affect their dose-concentration-effect relationship. Through lectures and workshops, the course sheds light on how the relationships affect both drug development and use, in comparison with more traditional drugs.

The course focuses on protein medicines and antibodies, but also covers other types of biological medicines such as peptides, oligonucleotides, vaccines and cell therapies. We also discuss how knowledge about how the dose-response relationships of biological medicines in preclinical studies are used to define clinical study design.

More information


Department of Pharmacy

Biomedicinskt Centrum BMC, Husargatan 3 752 37 Uppsala

Box 580, 751 23 UPPSALA

Study counsellor


Telephone: +46 18 471 44 36